The global SGLT-2 Inhibitors Market is projected to experience significant revenue growth over the forecast period, driven by the increasing prevalence of diabetes mellitus worldwide. According to the World Health Organization (WHO), the number of people with diabetes has risen from 108 million in 1980 to 422 million in 2014, with a particularly rapid increase in low- and middle-income countries.

https://www.reportsanddata.com..../report-detail/sglt-